United States
Brazil
Canada
Germany
India
Ireland
Japan
Mexico
New Zealand
Philippines
South Africa
United Kingdom
Unblinded: A Clinical Trial Podcast
Similar topics: pharma and clinical
Chart positions today · Australia
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the India charts we track today.
Not on the Japan charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like The Top Line, try…
AI For Pharma Growth
Similar topics: pharma and diagnostic
What Pharma Needs Next
Similar topics: pharma and biopharma
PwC's Next in Health
Similar topics: medtech and pharma
Conversations in Drug Development
Similar topics: pharma and drug
BioCentury This Week
Similar topics: pharma and biopharma
Ranking history · Australia
No ranking history for this show in Australia over the last 7 days.
Latest episodes
-
Inside Teva's Weltruza launch and Novo's GLP-1 strategy
October 16, 2026 · 25 minIn this week's episode of "The Top Line," we're looking at two companies building on recent successes and pursuing new opportunities in the pharmaceutical industry. From Teva's growing portfolio of innovative medicines to Novo's expanding…
-
The Next Chapter for AI in Clinical Trials [Sponsored]
October 15, 2026 · 33 minClinical AI is moving from systems that predict and summarize toward agents that can help execute parts of a workflow. In this sponsored episode of The Top Line, Will Hurth speaks with Saama’s Ari Srinivasan, chief customer success and…
-
How AI could improve clinical trial decision-making (Sponsored)
October 12, 2026 · 23 minWhat if clinical development teams could evaluate potential trial outcomes before a study reaches patients? In this sponsored episode of The Top Line, host Irena Luo speaks with Raja Shankar, vice president for machine learning within AI…
-
How we picked the Fierce 15
October 9, 2026 · 23 minWhat does it mean to be a Fierce 15 biotech in 2026? With this year’s list unveiled, the Fierce Biotech team gets together to discuss what the winners tell us about the state of the sector.In this week’s episode of "The Top Line," the…
-
Locking in on pharma’s consumerization trend
October 2, 2026 · 19 minWith GLP-1s paving the way, a consumer shift is happening across markets for certain branded pharmaceuticals. Now, the CEO of a buzzy pattern-hair-loss biotech is eyeing opportunities in an evolving market that could expand well beyond his…
Show 7 more episodesShow fewer episodes
-
Fierce Pharma Week: A look at the biggest trends, campaigns and conversations
September 25, 2026 · 25 minFierce Pharma Week brought thousands of people to Philadelphia for four days of conversations about pharma marketing, commercialization, medical affairs and communications. In this episode of "The Top Line," Fierce editors share the…
-
Inside the growing world of biopharma prediction markets
September 18, 2026 · 24 minPrediction markets are opening up new ways to bet on biopharma events, from clinical trial readouts to FDA approvals. But they also create a new set of risks for an industry where employees, researchers, contractors and others may have…
-
Clinical trials reach a new automation inflection point (Sponsored)
September 14, 2026 · 17 minClinical development organizations are facing mounting pressure to do more with increasingly complex protocols, larger data sets and tighter timelines. While automation has improved individual processes, many of the industry's most…
-
The future of RAS inhibitors
September 11, 2026 · 29 minRevolution Medicines recently made history with the approval of its RAS inhibitor Rasonque for advanced pancreatic cancer. But behind RevMed is an entire field of biotechs working to broaden the reach of RAS-targeting drugs. In this…
-
The people who stayed with the problem
September 4, 2026 · 25 minThe 2026 Fierce 50 includes people and organizations working on very different problems across biopharma and healthcare, from designing new proteins and developing cancer medicines to protecting vaccine science, improving health literacy…
-
Why Diagnostic-Driven Therapies Still Miss Eligible Patients (Sponsored)
September 2, 2026 · 13 minThe promise of precision medicine depends on more than scientific innovation. It also depends on whether eligible patients can be identified, tested and connected to the most appropriate treatment. In this episode of The Top Line, host…
-
MrBeast, Snapchat, AI and more: Pharma marketing’s pulse check
August 28, 2026 · 21 minAs Fierce Pharma Week approaches, the Fierce Pharma Marketing team is taking stock of some of the biggest trends reshaping how drugmakers and healthcare agencies reach audiences. In this week’s episode of “The Top Line,” Fierce’s Ben…
About the show
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.